Short answer
OPKO HEALTH, INC. (OPK) filed an 8-K current report with the SEC on March 19, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Appointment of Subbarao V. Uppaluri, Ph.D. to OPKO's Board, effective March 18, 2026, filling vacancy from Dr. Krasno's passing.
OPKO HEALTH, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Appointment of Subbarao V. Uppaluri, Ph.D. to OPKO's Board, effective March 18, 2026, filling vacancy from Dr. Krasno's passing
- Dr. Uppaluri qualifies as independent per SEC and Nasdaq rules, enhancing governance credibility
- Expected to join Compensation Committee, influencing executive pay and incentive oversight
- Extensive prior executive experience with OPKO and other public companies, adding financial and strategic expertise
- Compensation under standard non-employee director terms as per 2025 Proxy Statement, no conflicts of interest disclosed
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other OPKO HEALTH, INC. 8-K filings
Get the next OPK 8-K as it lands
Follow OPK for push alerts, or ask the research agent what this filing means.